Circulating tumour cells and PD-L1-positive small extracellular vesicles: THE liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer
Low-hyperinsulinaemic and high-quality diet as per HEI-2015 can reduce the risk of kidney cancer development, kidney cancer-specific death, and all-cause mortality.
Deprived colorectal patients get treated later and died earlier than their affluent counterparts, leading to up to 25 days less being alive and treated within the first year after diagnosis
Selection of Treatment Options for Locally Advanced Rectal Cancer: An MRI-based Risk Stratification Scoring System
We developed the mrDEC scoring system to accurately predict the prognosis of patients with LARC and to distinguish true high-risk patients from low-risk patients.
Minimally invasive testing using molecular approaches for endometrial cancer diagnosis: the game-changer in cost-effective detection among women with postmenopausal bleeding
First phase II/III trial to verify the efficacy and safety of trifluridine/tipiracil plus bevacizumab as second-line treatment for patients with metastatic colorectal cancer
Contributors: Yasutoshi Kuboki and Takayuki Yoshino; Department of Experimental Therapeutics and Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan